What if what yesterday was pricks and pain, tomorrow is pills and comfort?

Proteins used as medicines are a reality in 20th century medicine. XXI. These are used to treat a multitude of diseases, such as some types of cancer, diabetes or hemophilia.

One of the problems that peptides generally present is their low stability under the conditions that occur in the gastrointestinal tract. This means that most peptides cannot be administered orally and must be injected, which complicates their production process and the regulations they must comply with.

Well, this could begin to change thanks to the advances made by Christian Heinis’ Swiss research group. For the first time, it has been possible to develop a peptide with a specific target that overcomes the conditions that occur in the gastrointestinal tract. Although there is still a long way to go, this opens the doors to a new generation of peptide medications where the pharmaceutical form would cease to be an injectable and become an oral solid.